Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to...

Endocrine Related Cancer 2007 / 06 Vol. 14; Iss. 2

Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor- , CH11 and CYC202

Mody, M., Dharker, N., Bloomston, M., Wang, P.-S., Chou, F.-S., Glickman, T. S, McCaffrey, T., Yang, Z., Pumfery, A., Lee, D., Ringel, M. D, Pinzone, J. J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Endocrine Related Cancer
DOI:
10.1677/ERC-06-0003
Date:
June, 2007
File:
PDF, 272 KB
english, 2007
Conversion to is in progress
Conversion to is failed